{"name":"ACT Biotech, Inc","slug":"act-biotech-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Cisplatin, Capecitabine, Telatinib","genericName":"Cisplatin, Capecitabine, Telatinib","slug":"cisplatin-capecitabine-telatinib","indication":"Metastatic non-small cell lung cancer, Metastatic breast cancer, Metastatic colorectal cancer, Renal cell carcinoma","status":"phase_2"}]}],"pipeline":[{"name":"Cisplatin, Capecitabine, Telatinib","genericName":"Cisplatin, Capecitabine, Telatinib","slug":"cisplatin-capecitabine-telatinib","phase":"phase_2","mechanism":"Cisplatin works by crosslinking DNA, thereby inhibiting DNA replication and transcription, while Capecitabine is a prodrug that is converted into 5-fluorouracil, which inhibits thymidylate synthase, and Telatinib is a tyrosine kinase inhibitor that targets the VEGFR and PDGFR pathways.","indications":["Metastatic non-small cell lung cancer, Metastatic breast cancer, Metastatic colorectal cancer, Renal cell carcinoma","Head and neck cancer"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTFB1N2d4NnYwN0JiU181Tm9vV0dUM1c1NWVMUHNCdlZFVmRSZXpmRFp3TnBQUVJXYnFYV1VlNVBIZXU0TzY4bE5BNTd4NGpIT21aYlZHMy1qSW1HWDFH?oc=5","date":"2026-04-06","type":"pipeline","source":"BioSpace","summary":"Layoff Tracker: BioNTech Will Close Singapore Plant, Affecting 85 Employees - BioSpace","headline":"Layoff Tracker: BioNTech Will Close Singapore Plant, Affecting 85 Employees","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxQZnptdnZFdFZRVWhWVDdMVHNhY19EU1hya0stZ2dDbHZoZnJNWExlSGF5bks2ejVsRjU2LXZpTW1sb0wtWFBWTG4zVXowc0tvd0NvcTVibU12R1JFVGs3MUhYeG4wX3J0dmg0WjNfQTV6NkxBVHQxTndyTEdnRHctMklHUQ?oc=5","date":"2026-03-11","type":"pipeline","source":"KFF","summary":"Key Facts About Medicare Drug Price Negotiation - KFF","headline":"Key Facts About Medicare Drug Price Negotiation","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-01-02","type":"pipeline","source":"SiliconValley.com","summary":"‘Biosecure Act’: New bill forces California biotech firms to cut ties with Chinese companies - SiliconValley.com","headline":"‘Biosecure Act’: New bill forces California biotech firms to cut ties with Chinese companies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxOcU43X3FhQXVwNzRXbUVVWDNRWTBaQnczVjM4STJRenozT05RcHg4UFNGSzhCNXJrQ2xwSDRQa0NnYndlWHlJcTUyblVHR2dUSk5pRVlRMDdMbG5QWGtZOGdzUW51U2IzR0oxbUl6SjJ0dFRoN1RBbFZ5cjJCTHNXcm5pdHFZaHJtMHVNbGkzZ09lZHNza0Zpd2VBTktHQUF3Nl9IQlVJeEp0aXhOeHptdG13?oc=5","date":"2025-12-31","type":"pipeline","source":"Latham & Watkins LLP","summary":"BIOSECURE Act Becomes Law, Limiting Grants With “Biotechnology Companies of Concern” - Latham & Watkins LLP","headline":"BIOSECURE Act Becomes Law, Limiting Grants With “Biotechnology Companies of Concern” - Latham & Watkins LLP","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE9qNy1UNS1rXzh3dUw2aFFTQWRoSC1FRnZoXzRqNDRrNU0xdEdCVzJ5VGpITVpOY2VVOWdYYm5BaHVJWU9jcXFRUk9NZzVxb2Fza0ptdWRWd09jS3dwYU1Mb0c0dllHNDMwUnFWdmxn?oc=5","date":"2025-12-22","type":"deal","source":"KED Global","summary":"Samsung Biologics to buy its first US drug factory from GSK for $280 mn - KED Global","headline":"Samsung Biologics to buy its first US drug factory from GSK for $280 mn","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE0zNTdqQ2FudFNPLXM0ajdDRWtycU1BM2RrbjBDbGZ6T0xZaDRKT2dOekV0SzRhb1NhMFZJSHljWmszRkxjTk1hQW13eTN1bmxXZDQzY3FVNmRmeUFjemhMS0Q5dHNXUEVJb3RyOWZ3?oc=5","date":"2025-12-18","type":"pipeline","source":"KED Global","summary":"South Korean biotech firms poised for gains from US BIOSECURE Act - KED Global","headline":"South Korean biotech firms poised for gains from US BIOSECURE Act","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxOWmVCU1VSVkg2cEM4X2cyYjZmMUJ2N09wVmZTX21QelJKWXc1SUJHN0hCRV9UNU1peXpfR0hiSnItTnphengzUURtRjk2M0p2cmdFY0lnamplWnljV0pILWdYal9OTHZfU3FxNnNhbVhRWFlNODV6blVIZENRSUlMbDh2TTZiLXV3ZnBmUjhvby1BTU1w?oc=5","date":"2025-12-15","type":"pipeline","source":"Pharma Voice","summary":"After years of debate, the Biosecure Act could be headed for Trump’s desk - Pharma Voice","headline":"After years of debate, the Biosecure Act could be headed for Trump’s desk","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxPV0YyanZfVDlUdk5EckNwLTRCRUhWVm5rYUotQUhCZ2RhVWVLRXA1eVJVZEdWekV2U0tNSGNmdlFpY3RpWmp4SEFFdUZQcWwxanVoSVFKNXA2Y1A3OXNaZGsxalR0NGpiTXpHSUFIMi1xVUwyRThQTWVJQzJfcUZlQlEycUJEclZfZUVZbDdPWDFEWlAtNlpn?oc=5","date":"2025-12-10","type":"pipeline","source":"statnews.com","summary":"A weakened bill to cut off Chinese biotech firms nears passage, after years of changes - statnews.com","headline":"A weakened bill to cut off Chinese biotech firms nears passage, after years of changes","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxOQkZLWUZlVGNOeHRnLWE1TVFHdE1aMVliN2Via1lWMFRBdXQ3V0FOWXBTb1JyRWJhQUc0Y1ZCVWNvVENIR2lCeWREV0RxamcyWnhaXzZ2MC1xTW9BTDRIWVh1cnRBSDdXSU1ZYVNBbWV6aGpHY3U2WkRpY080MlVOeFB2bUw2OEZsbkxqcVVhd0oxMFBxczZodlpWTy1BZUIycGxveENIU3c2ZHJxbVBuc25fSTBOQUtDRFBR?oc=5","date":"2025-10-10","type":"pipeline","source":"Fierce Pharma","summary":"Senate endorses Biosecure Act successor, adopting softer tone and omitting WuXi companies - Fierce Pharma","headline":"Senate endorses Biosecure Act successor, adopting softer tone and omitting WuXi companies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxNSHlwY1BPbDhxcFFibl9jRmJtek9rVGtqS09LcERzN0NuMUx4SExxbzdHeWlLSUlSWllueVpXby0xdjRDWU5aMkFhS1hxc1lCWE9wVnhkcjNYVzdWTk9QY05OX1RWWFdKOUxFYW52QkpBU1FONE5OdzRBTzFSUFByZVVoVUlJbjk1WGZZazhxaEZQSlI4ZXNqSDZUb0Z0RFJXUEZQbHU5Z21uOTgzbGc?oc=5","date":"2025-09-12","type":"pipeline","source":"Investing News Network","summary":"PharmaCyte Biotech, Inc. Announces $7 Million Capital Raise Led by Existing Investors - Investing News Network","headline":"PharmaCyte Biotech, Inc. Announces $7 Million Capital Raise Led by Existing Investors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxNeF9ZbHJEX3FtckQ0LVYwejd6dWJ2dHdxVEdHdTktMW9NaEdwYm5wODl3cDFVYjJuR3RaaW00bDhLamZPQ2xUN183aHR1alR1WjN4MW5kUmtYR1NYRkZRWGlJYkdhZFhjNGl1VFhsZEFXRTBibHVsSzJ4VXBNWExhNllpLTItandSdjFRVXhtaUw?oc=5","date":"2025-07-24","type":"pipeline","source":"KrASIA","summary":"Hong Kong biotech enters its second act with a licensing supercycle - KrASIA","headline":"Hong Kong biotech enters its second act with a licensing supercycle","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxOV0VBc3RsNURVVjB5cW95Sk9Kc2xmeG5ncmZLMXpDZFpxS3J0elhNd1FuSDhIZTZRLTRZNTdlWXZZQ2pIa2pmblMtTTVEZVJYY2lIOTNkU0ZNWWx0LWMzaEJUdnFydm1ULU9McnNuOVBZX0tScHQwTW01c3JyZVdNUmxxUjdNYXROQzRUQmxfVmpUMlFzbkh2dWtVV3R1ZVNhUWJsVFdOT01WT1RPYm9UR0laOA?oc=5","date":"2025-05-06","type":"pipeline","source":"Fierce Biotech","summary":"Anti-aging biotech NewLimit raises $130M to push liver reprogramming med into clinic - Fierce Biotech","headline":"Anti-aging biotech NewLimit raises $130M to push liver reprogramming med into clinic","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}